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Abstract: Enzymatic hydrolysis of the pyrophosphate bond of CDP- 
diglyceride (CDP-DG), previously shown to occur in bacteria, is demonstrable 
in mammalian tissues. Activity was enriched in a lysosomal fraction obtained 
from guinea pig cerebral cortex and was purified 92-fold relative to the homog- 
enate by a combination of XM-300 ultrafiltration and DEAE-cellulose column 
chromatography. When incubated with CDP-dipalmitin, the purified enzyme 
produced stoichiornetric amounts of CMP and phosphatidate. dCDP-DG 
served as a substrate, while ADP-DG was an inhibitor, as were 5’-AMP and 
5’-dAMP. CDP-DG hydrolysis was not affected by the presence of excess 
amounts of CDP-choline, CDP-glycerol, sodium pyrophosphate, or cyclic 
3‘,5’-AMP. Key Words: CDP-diglyceride hydrolase-lysosomes- 
Phosphatidate-Cytidine 5‘-monophosphate-Adenosine 5‘-monophosphate. 
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CDP-diglyceride (CDP-DG; 5’-cytidine diphos- 
pho- 1,2-diacyl-sn-glycerol) is an obligatory inter- 
mediate for the formation of the bacterial phospho- 
lipids. In eukaryotic cells, the liponucleotide is 
the biosynthetic precursor of two classes of phos- 
pholipids, the phosphatidylinositols and the phos- 
phatidylglycerols. CDP-DG has been isolated in 
minute amounts from mammalin liver (Thompson 
and MacDonald, 1975) and brain (Thompson and 
MacDonald, 1976) and has been found to be highly 
enriched in stearate and arachidonate, a pattern 
which closely resembles that observed in isolated 
diacylglycerol as well as in the phosphatidyl- 
inositols, but not seen in the phosphatidylglycerol 
series or in isolated phosphatidate (Thompson and 
MacDonald, 1976). 
The low rate of synthesis of CDP-DG and its low 
steady state content in brain and liver suggest that 
enzymes involved in its synthesis and degradation 
may be part of a regulatory mechanism in lipid 
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biosynthesis. The demonstration of a bacterial en- 
zyme that catalyzes the hydrolytic cleavage of 
CDP-DG to yield phosphatidate (PhA) and, CMP 
(Raetz et al., 1972; 1976), raised the possibility that 
the reaction also occurs in eukaryotic cells, where it 
could play a role in liponucleotide metabolism. Both 
the metabolic relationship of CDP-DG to lipids in- 
volved in the well-known “phospholipid labeling 
effect” (Hokin and Hokin, 1955; for reviews, see 
Michell, 1975; Hawthorne and Pickard, 1979) and 
current interest in release of arachidonate from tis- 
sue lipid stores contributed to interest in this hy- 
drolase. A preliminary account of this work has 
been presented (Rittenhouse et al., 1980). 
MATERIALS AND METHODS 
[5-3H]Cytidine-5’-monophosphate (15-30 Cilmmol) 
and [l-’4C]acetyl coenzyme A (50 mCi/mmol) were ob- 
tained from Amersham-Searle, Chicago, Illinois. [ 1J4C]- 
Abbreviations used: ara-A, Arabinosyl adenosine; ara-C, Ara- 
binosyl cytosine; CDP-DG, 5’-Cytidine diphospho-1,Z-diacyl- 
sn-glycerol; PhA, Phosphatidate, diacyl-sn-glycerol-3-phosphate; 
PhI, Phosphatidylinositol. 
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Tyramine (40-60 mCi/mmol) was a product of New En- 
gland Nuclear Corp., Boston, Massachusetts. [3H]- 
dCDP-diglyceride (0.23 mCi/mmol, labeled in the cy- 
tidine moiety) and unlabeled ADP-diglyceride were the 
generous gift of Dr. W.  Dawhan. Dipalmitoyl-sn- 
glycerol-3-phosphate (L-a-dipalmitoylphosphatidate), 
AMP, 2-deoxy AMP, CDP, D-ribose 5’-monophosphate, 
adenosine 5’-monosulphate, adenosine 5’-monophos- 
phoramidate, tetrasodium pyrophosphate, cyclic 3’,5’,- 
AMP, adenosine, CMP, IMP, CDP-choline, CDP- 
glycerol, and dipalmitoyl CDP-DG were products of 
Sigma Chemical Co., St. Louis, Missouri. Arabinosyl 
cytosine (ara-C), ara-CMP, arabinosyl adenosine (ara-A), 
and ara-AMP were obtained from P-L Biochemicals Inc., 
Milwaukee, Wisconsin. a,P-Methylene ATP and /3,y 
methylene ATP were purchased from Miles Laboratories, 
Inc., Elkhart, Indiana. Adenosine 5’-O-thiomono- 
phosphate was the product of Boehringer-Mannheim 
Biochemicals, Indianapolis, Indiana. Unlabeled dCDP- 
DG and 1-palmitoyl glycerol-3-phosphate (lysophos- 
phatidate) were obtained from Serdary Research Labora- 
tories, London, Ontario; Triton X-100 from Rohm and 
Haas Co., Philadelphia, Pennsylvania; Unisil from the 
Clarkson Chemical Co., Williamsport, Pennsylvania. 
Preparation of Subcellular Fractions 
For each experiment, three male guinea pigs (300-350 
g) were killed by stunning and exsanguination. Whole 
brains rostra1 to the colliculi were removed within 2 min 
and rinsed in 0.32 M-SUCrOSe. The cerebral cortices were 
then separated from underlying midbrain structures and 
excess white matter removed with a blunt spatula. The 
tissue (approximately 1.5-2.0 g wet weighvbrain) was 
homogenized in a glass homogenizer with 9 volumes of 
0.32 M-SUCTOSe. Subsequent fractionation of the homoge- 
nate was carried out as previously described (Schacht and 
Agranoff, 1972). The postmitochondrial supernatant was 
further separated into microsomal (P3) and high-speed 
soluble fractions (S,) by centrifugation at 105,000 g for 60 
min. Subcellular fractions were resuspended in 0.32 M- 
sucrose to yield protein concentrations of 2-10 mg 
proteidml. 
A subfraction enriched in lysosomes was prepared from 
the P2 pellet (crude mitochondria1 fraction) by the 
“chemical field method” of Lisman et al. (1978). The 
mitochondria-enriched fraction was taken as “fraction 1” 
after low-speed centrifugation of the P2 fraction in the 
presence of succinate. The lysosome-enriched fraction in 
the present study represented pooled fractions 1-5 after 
the second ultracentrifugation step described by Lisman 
et al. (1978). 
Preparation of PHICytidine 
Diphosphodipalmitoyl- sn- 
Glycerol (f’H]CDP-Dipalrnitin) 
[3H]CMP-morpholidate was prepared by the reaction of 
0.5 mmol of [3H]C!MP (350 pCi/mrnol) with 2 mmol each 
of morpholine and of N, N ‘-dicyclohexylcarbodiimide, 
and [3H]CDP-dipalmitin was prepared from 0.3 mmol of 
dipalmitoyl PhA and an equimolar amount of the resultant 
labeled CMP morpholidate (Agranoff and Suomi, 1963). 
After 4 days, the reaction mixture was dried in a rotary 
evaporator under reduced pressure and dissolved in 
chloroform/methanol/6 M-HCl (200: 100: 1, by vol.). The 
mixture was washed twice with an added aqueous upper 
phase from which unreacted [3H]CMP-morpholidate was 
removed. The [3H]CDP-dipalmitin product was further 
purified by silica gel chromatography. The lipid extract 
was applied to a column (10 x 1.5 cm) containing 10 g of 
Unisil which was treated sequentially with 200-ml vol- 
umes of chlorofordpyridinelformic acid (50:30:7, by 
vol.), chloroform, and chloroforndmethanol (3:2, vlv). 
The [3H]CDP-dipalmitin was eluted in the latter fraction 
and dried under reduced pressure. The product was sus- 
pended in 1 -2 ml of cold water, and an equimolar amount 
of Tris base was added incrementally with frequent 
sonication to avoid the possibility of alkaline hydrolysis of 
the ester bonds. The pH of the milky suspension was then 
adjusted to 7.4 with additional Tris if necessary, using 
narrow-range indicator ‘paper, and then stored at 4°C. 
Under these conditions, less than 5% breakdown oc- 
curred over a 2-month period. Some 10-40% of the 
labeled morpholidate was converted to the liponu- 
cleotide. Purity of the product was in excess of 95% as 
judged by TLC and high-voltage electrophoresis (HVE). 
Thin-Layer Chromatography 
Solvent systems employed were: (A) chloroform/ 
methanoVacetic acidwater (50:25:7:3, by vol.) and (B) 
chlorofordpyridinelformic acid (50:30:7, by vol.) as de- 
scribed by Raetz et al. (1976). Silica gel G or HPTLC 
plates (E. M. Merck) were obtained from Brinkman In- 
dustries, Des Plaines, Illinois. Lipids were visualized by 
lipid phosphorus spray (Dittmer and Lester, 1964) or by 
charring with sulfuric acid reagent (Fewster et al., 1969). 
High- Voltage Electrophoresis 
Samples were applied to Whatman No. 1 filter paper in 
buffer and subjected to HVE at 4000 V for 30 min in the 
same buffer. To follow CMP-morpholidate synthesis, a 
0.05 M-sodium tetraborate buffer (pH 8.7) was employed. 
CMP-morpholidate migrated 10 cm, while CMP migrated 
14 cm. For enzyme product identification, a pyridine/ 
acetic acid/water mixture (14:40:356, pH 4.3) was 
employed. CDP-DG remained at the origin and cytosine 
and cytidine moved toward the cathode, while CMP and 
CDP migrated anodally 6 cm and 9 cm, respectively. 
Assay of CDP-DG Hydrolase 
The standard enzyme assay medium contained 0.1 M- 
Tris-maleate buffer (pH 4.8), 0.3% Triton X-100 (wlv), 
0.28 m~-[~H]CDP-dipalmitin (0.35 mCi/mmol) and 1 - 150 
pg of enzyme protein in a final volume of 0.1 ml. The 
reaction was initiated by the addition of lipid substrate, 
which had been sonicated for 15 s. Assays were per- 
formed at 37°C for 30-60 min, and the reactions termi- 
nated by the addition of 1.12 ml of chforoform-methanol 
(1:2, v h ) .  The lipid components of the incubation mixture 
were then separated from water-soluble products by the 
further addition of 0.025 ml of 6 M-HCI, 0.38 ml of chlo- 
roform, and 0.58 ml of H20 (Hajra et al., 1968). The two 
phases were then separated by low-speed centrifugation 
at room temperature, and 1.0 ml of the clear overlying 
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aqueous layer was carefully removed and dried in a 
counting vial under a stream of N,. Radioactivity was 
determined after the addition of 1 ml of water and 10 ml of 
ACS scintillation cocktail (Amersham Searle, Chicago, 
Illinois). Counting efficiency for 3H was approximately 
25%, as determined by an internal standard method. Ob- 
served enzyme activity was corrected for the amount of 
radioactivity present in the aqueous phase of zero time 
incubations (1.5 -3% of radioactivity initially added). 
Assay of Marker Enzymes 
Succinate dehydrogenase (EC 1.3.99.1) was deter- 
mined by measuring succinate-dependent reduction of 2- 
(p - iodophenyl) - 3 - (p - nitrophenyl- 5 -phenyltetrazolium) 
chloride (INT), using the procedure of Porteus and Clark 
(1965). Acetylcholinesterase (EC 3.1.1.7) was determined 
by the method of Ellman et al. (1961), with the exception 
that the assays included lo-,' M-tetraisopropylpyrophos- 
phoramide to inhibit pseudocholinesterase (Hoover et al., 
1978). Choline acetyltransferase (EC 2.3.1.6) was deter- 
mined by the procedure of Fonnum (1975). Monoamine 
oxidase (EC 1.4.3.4) was determined by the method of 
Donnelly et al. (1976), using ['4C]tyramine as substrate. 
P-Galactosidase (EC 3.2.1.23) and P-glucuronidase (EC 
3.2.1.31) activities were determined at pH 5.0 spec- 
trophotometrically , as described by Cotman and Mat- 
thews (1971), using p-nitrophenyl-0-D-galactoside and 
p-nitrophenyl-0-D-glucuronide as substrates. 
Chemical Determinations 
Protein was determined spectrophotometrically (Geiger 
and Bessman, 1972), using bovine serum albumin as a 
standard. To circumvent interference by Triton X-100 or 
Tris-HC1 buffer, protein was first precipitated by addition 
of sodium deoxycholate and trichloroacetic acid prior to 
estimation (Bensadoun and Weinstein, 1976). Total lipid 
phosphorus was determined by the method of Ames and 
Dubin ( 1  960). 
RESULTS 
Characterization of CDP-DG Hydrolase 
Activity in Homogenates 
CDP-DG hydrolase activity, as measured by the 
release of water-soluble radioactivity, was linear 
with respect to time of incubation for up to 90 min 
and with amounts of protein up to 150 kg under 
conditions of partial substrate utilization. Incuba- 
tion times and amount of enzyme were sub- 
sequently maintained so that less than 25% of the 
substrate routinely underwent hydrolysis. The ad- 
dition of Triton X-100, to a find concentration of 
0.2-0.3%, stimulated enzyme activity 7- 10-fold 
(Fig. 1). A broad acidic pH optimum (4.5-5.0) for 
enzyme activity was observed in guinea pig cerebral 
cortex homogenates, under which conditions spe- 
cific activity was 0.33 2 0.11 nmol (s.D.) of water- 
soluble radioactivity released per min per mg of 
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FIG. 1. Effect of Triton X-100 on CDP-diglyceride hydrolase 
activity. Homogenate (78.4 f ig  protein) was incubated in the 
standard incubation medium for 60 min in the presence of 
different concentrations of Triton X-100, as indicated. The 
reactions were terminated as described in Materials and 
Methods, and the amount of water-soluble radioactivity 
determined. 
Subcellular Localization of CDP-DG Hydrolase 
To establish the subcellular site of CDP-DG hy- 
drolase activity, cerebral cortex homogenates were 
fractionated by differential and sucrose-density 
centrifugation and the subcellular fractions obtained 
assessed for cross-contamination, by means of spe- 
cific marker enzymes. The greatest enrichment of 
CDP-DG hydrolase was associated with the 
mitochondrial-lysosomal (P2C) fraction (Table 1). In 
four separate experiments, this fraction showed an 
R.S.A. (relative specific activity) of 4.00 2 0.48 
when compared to the homogenate. The only other 
subcellular fraction which exhibited significant en- 
richment of activity was the synaptosomal fraction 
(R.S.A. = 1.34 -t 0.46, n = 3). The mitochondria1 
marker enzymes, succinate dehydrogenase and 
monoamine oxidase (SDH, MAO), were enriched in 
the P,C fraction to an extent similar to that of 
CDP-DG hydrolase, although the R.S.A. values for 
both SDH and M A 0  were consistently lower than 
CDP-DG hydrolase in the synaptosomal fraction. 
To ascertain whether CDP-DG hydrolase existed 
in a latent form, the P2C fraction was subjected to 
rapid freeze-thaw treatment. As shown in Table 2, 
this procedure resulted in an almost quantitative 
release of CDP-DG hydrolase activity into the solu- 
ble fraction, along with two lysosomal marker en- 
zymes, P-galactosidase and p-glucuronidase. In 
marked contrast, the freeze-thaw treatment re- 
leased little or no SDH or MA0 activity from the 
P2C fraction and, in fact, resulted in a significant 
enrichment of these enzymes in the particulate 
fraction. Further evidence to suggest a lysosomal 
localization for CDP-DG hydrolase was obtained 
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TABLE 1. Subcellular distribution of CDP-diglyceride hydrolase in guinea pig cerebral cortex 
~ ~ 
Relative specific activity 
% CDP-diglyceride Monoamine Succinate Choline 
Fraction Protein hydrolase oxidase dehydrogenase acetyltransferase Acetylcholinesterase 
~~ ~ 
P, (crude 
nuclear pellet) 15.6 0.78 0.41 0.67 0.45 0.40 
P,A (myelin) 4.02 0.37 0.21 0.09 0.26 0.58 
P,B (synaptosomal) 5.41 1.76 0.52 0.53 2.40 0.38 
P2C (mitochondriaV 
lysosomal) 11.3 3.34 4.60 4.71 0.81 0.27 
P, (microsomal) 24.5 0.81 0.62 0.18 0.96 1.81 
S, (soluble) .‘ 21.2 0.30 0.00 0.00 1.07 0.30 
% Recovery 82.1 75.0 67.0 71.1 76.0 64.3 
Subcellular fractions were prepared as described in Materials and Methods and assayed for CDP-diglyceride hydrolase and marker 
enzyme activities. The relative specific activity is defined as the specific activity of the fraction relative to that of homogenate. Actual 
specific activities (nmoVmg proteidmin) in the homogenate were as follows: CDP-diglyceride hydrolase, 0.27; monoamine oxidase, 1.98; 
succinate dehydrogenase, 14.7; choline acetyltransferase, 0.74; acetylcholinesterase, 82.0. Protein in homogenate was 112 mgig wet 
weight. Results are from one of three experiments that gave similar results. 
from subcellular fractionation experiments involv- 
ing the “chemical field” method, whereby the 
sedimentation rate of mitochondria is increased by 
the addition of succinate, facilitating the separation 
of lysosomes from contaminating mitochondria. 
Using this technique, lysosomal fractions obtained 
from the crude mitochondrial fraction (P2) were en- 
riched in both @-galactosidase (R.S.A. = 3.85) and 
CDP-DG hydrolase (R.S.A. = 3.03) and contained 
only small amounts of SDH (R.S.A. = 0.68). In 
agreement with the findings of Lisman et al. (1978), 
they retained significant MA0 activity (R.S.A. = 
2.06), indicating contamination of the fraction with 
detached outer mitochondrial membranes. 
Purification of CDP-DG Hydrolase 
The P,C fraction obtained from three guinea pig 
cerebral cortices was routinely used as the starting 
preparation for enzyme purification, and was 
dialyzed at 4°C against at least two 1-liter changes of 
1 mM-sodium phosphate buffer (pH 7.4) over a 24-h 
period. The dialysand was rapidly frozen in an 
acetone-Dry Ice bath and thawed three times, and 
the suspension centrifuged at 14,500 g for 20 min. 
The supernatant fraction was drawn off carefully in 
order to avoid contamination of the pelleted debris. 
More than 85% of the initial CDP-DG hydrolase ac- 
tivity present was recovered in a soluble form, 
yielding a 16.5-fold enrichment over the total ho- 
mogenate (Table 3). Additional freeze-and-thaw 
tteatment of the P,C fraction did not release further 
enzyme activity. The preparation was unstable at 
4°C or -20°C at this step. The solubilized enzyme 
was diluted 10-fold with 1 mM-sodium phosphate 
buffer (pH 7.4) and transferred to an Amicon Model 
12 stirred ultrafiltration cell containing an XM-300 
membrane (nominal mol. wt. cutoff >300,000). The 
solution was concentrated to approximately I ml at 
less than 8 psi. The concentrated enzyme was di- 
luted to 10 ml with 10 mM-Tris-HCi buffer (pH 7.4) 
and concentrated to less than 1 ml by a repetition of 
the ultrafiltration step. The retentate contained 
more than 80% of the applied hydrolase activity and 
had a specific activity approximately twofold that of 
the supernatant fraction from the freeze-thaw 
TABLE 2. Co-jiractionation of CDP-diglyceride hydrolase with lysosomal marker enzymes 
Relative specific activity 
CDP-diglycende Monoamine Succinate 
Fraction h ydr‘olase oxidase dehydrogenase p-Galactosidase p-Glucuronidase 
MitochondriaV 
lysosomal (P,C) 4.48 4.45 4.81 4.32 5.11 
Supernatant 19.84 0.09 N.D. 17.3 7.54 
Particulate 2.10 5.86 5.79 2.06 2.93 
~~ ~ 
Mitochondrial-lysosomal fraction (P,C) was frozen and thawed three times in an acetone-Dry Ice bath and centrifuged at 
14,500 g for 20 min to obtain particulate and supernatant fractions. CDP-diglyceride hydrolase and marker enzyme activities 
were then measured in these fractions in addition to initial homogenate. Values expressed are relative specific activities. Ac- 
tual specific activities in the homogenate (nmoYmg proteidmin) were as follows: CDP-diglyceride hydrolase, 0.30; succinate 
dehydrogenase, 18.5; monoamine oxidase, 5.2; p-glucuronidase, 0.29; p-galactosidase, 0.41. Results are from one of two ex- 
periments that gave similar results. N.D., not detectable. 
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TABLE 3. Purification of CDP-diglyceride hydrolase from guinea pig cerebral cortex 
Specific activity 
Fraction Protein (mg) (nmoYminlmg protein) Yield (%) Purification 
Total homogenate 35 1 0.24 100 1 .o 
Mitochondria1 (P2C) 33.3 0.98 38.9 4.1 
Freeze and thaw treatment 8.24 3.96 38.8 16.5 
Ultrafiltration (XM-300) 2.35 7.38 20.6 30.9 





3 and 4) 
retentate 
Ultrafiltration (PM-10) 0.62 220  16.2 91.8 
See text for experimental details. 
treatment. The XM-300 retentate lost more than 
25% activity after storage at 4°C for 24 h in the 
absence of detergent, but could be stabilized by the 
addition of Triton X-100 to a final concentration 
of 0.2%. 
Chromatography of the XM-300 retentate fraction 
on a DEAE-cellulose column resulted in a sharp 
peak of hydrolase activity emerging from the col- 
umn at 0.025-0.05 M-NaCl (Fig. 2). More than 90% 
of the activity recovered was present in fractions 3 
and 4. These combined fractions constituted a 
twofold purification relative to the XM-300 reten- 
tate. The specific activity of the most active fraction 
(3) was increased more than fourfold relative to the 
XM-300 retentate fraction. In some experiments the 
peak of CDP-DG hydrolase activity was eluted from 
the column in fraction 4 rather than fraction 3, and 
therefore both were routinely combined. 
The pooled fractions were concentrated and freed 
of excess Triton X-100 by ultrafiltration, using a 




stirred ultrafiltration cell, at less than 40 psi. Before 
ultrafiltration, the pooled fractions were diluted to 
30 ml with 10 mM-Tris-HC1 (pH 7.4), containing 
30% ethylene glycol (wh)  and 10% ethanol in order 
to break up the Triton X-100 micelles (Frasch, 
1975). To remove remaining detergent, the enzyme 
was concentrated to 1 ml and diluted to 10 ml with 
10 mM-Tris-HC1 (pH 7.4) containing 30% ethylene 
glycol (wh) and 10% ethanol, and concentrated 
again to 1 ml. The concentrated enzyme was then 
washed in the same manner with two 10-ml portions 
of 1 mM-sodium phosphate buffer (pH 7.4) to re- 
move the ethylene glycol and ethanol. The purified 
enzyme remained unstable in the absence of deter- 
gent, and the final enzyme concentrate (1 ml) was 
made 0.2% in Triton X-100. More than 80% of the 
enzyme activity in the pooled fractions following 
DEAE-cellulose chromatography was recovered 
following ultrafiltration and represented a 90-fold 
enrichment of activity relative to the initial homog- 
enate. The purified enzyme was stable for at least 4 
-o,6 FIG. 2. DEAE-cellulose chromatography 
of CDP-diglyceride hydrolase. An aliquot 
of protein (1.7 mg) from the XM-300 ul- 
trafiltration step was applied to a 5 x 0.5 
0 cm column containing Whatman DE-52. 
: equilibrated with 10 mM-Tris-HCI buffer ’ 0.4 h 0 (pH 7.6) containing 0.2% Triton X-100. 
cn After six column washes with the equili- 
Y E brating buffer, a linear NaCl gradient (0 to 
0.4 M, in equilibrating buffer) was applied 
0 c 
0 -- to the column. The flow rate was main- 
tained at 24 ml/h and 5.6-ml fractions 
h were collected. Fractions 1 to 20 were as- 
sayed for CDP-DG hydrolase activity as 
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months at 4°C. The specific activities of the PM-10 
retentate enzymes obtained in separate experiments 
varied from 22 to 43 nmol CDP-dipalmitin hydro- 
lyzed per min per mg protein. 
Identification of Products 
In order to eliminate possible complications due 
to the presence in the homogenate of nucleotidases 
and PhA phosphohydrolase activities, product iden- 
tification was carried out with purified PM-10 re- 
tentate fraction. An incubation mixture containing 
56 nmol of [3H]CDP-dipalmitin was incubated for 
4.5 h at pH 4.8 in the standard enzyme assay mix- 
ture. Following addition of the acidified chloro- 
form-methanol and separation of phases, a 0.5- 
ml aliquot of the aqueous layer was dried under 
Nz, dissolved in 0.05 ml of HzO, and subjected to 
high-voltage electrophoresis at pH 4.3 with CMP, 
CDP, and cytidine standards. The derivatives were 
located by UV absorption, cut out, and counted. All 
of the recovered activity was found in the CMP 
spot. The organic layer from the extracted incuba- 
tion mixture was dried under Nz, redissolved in 
chloroform-methanol (2:1), and applied to a TLC 
plate in solvent system B, together with standards of 
PhA, lyso-PhA, and diacyl glycerol. Areas corre- 
sponding to lipid markers were scraped and trans- 
ferred to Pasteur pipet columns plugged with glass 
wool. Lipids were eluted with two 5-ml volumes of 
chlorofordmethanol (3:2) and total phosphate was 
determined. A single lipid phosphorus spot with an 
Rf of 0.5 was found, which corresponds to that of 
authentic dipalmitoyl PhA. CDP-DG remains at the 
origin in this system. With solvent system A, the 
product co-migrated with authentic PhA with an R f  
of 0.83, while CDP-DG, lyso-PhA, and diacyl- 
glycerol had R;s of 0.28, 0.47 and 1.0, respective- 
ly. A very faint spot was seen in the lyso-PhA re- 
gion. Stoichiometry was calculated by comparison 
of aqueous phosphate released with that lost from 
the organic phase during a 6-h incubation in which 
>90% of CDP-DG was utilized (theoretical, 1.00; 
found, 1.07). 
Properties of the Purified Enzyme 
The PM- 10 retentate fraction displayed normal 
Michaelis-Menten kinetics towards CDP-dipalmitin 
in the concentration range 0.023-0.92 mM. A K ,  
value of 45 PM was calculated from linear regres- 
sion analysis of double-reciprocal plots (Fig. 3). The 
pH optimum was 4.8 (Fig. 4). Neither K+ nor Na+ 
ions (1 mM) had a significant effect on the hydrolase, 
while all divalent cations tested were inhibitory. 
HgZ+ was most potent, and produced 75% inhibi- 
tion, whereas Mg2+ was least inhibitory (16%). 
Other ions in order of descending inhibition were 
I /v 
I -I 
[CDP-dipalmitin] , mM 
.5 1.0 
FIG. 3. Effect of concentration of substrate (CDP-dipalmitin) 
on CDP-diglyceride hydrolase activity. Purified PM-10 reten- 
tate enzyme (3.3 pg protein) was incubated for 30 min in the 
presence of different substrate concentrations, in the range 
0.02 to 0.69 mM. Nonenzymic release of water-soluble 
radioactivity was determined at each substrate concentration 
and subtracted from the observed enzyme rates. A double- 
reciprocal plot of the data is shown in the inset. The calcu- 
lated value of the K,  is 45 p ~ .  
PH 
FIG. 4. Effect of pH on CDP-diglyceride hydrolase activity. 
Enzyme (2.5 pg protein), obtained from pooled fractions 3 
and 4 following DEAE-cellulose chromatography, was incu- 
bated for 30 min in the presence of 0.1 M-Tris-maleate buffers 
(pH 3.3-6.8, 8- - -0) or 0.1 M-Tris-HCI buffers (pH 7.0-8.0, 
0- --0). Nonenzymic water-soluble radioactivity was de- 
termined at each pH and subtracted from the observed en- 
zyme rates. 
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Mn2+, Cu2+ Ca2+, and Zn2+. The addition of either 
5 mM-EDTi or -EGTA in the absence of added 
divalent cations did not affect enzyme activity. 
Substrate Specificity 
A number of potential substrates and inhibitors 
were examined with the purified enzyme for their 
possible effects on CDP-DG hydrolase. Of the 
liponucleotides, both dCDP-DG and ADP-DG were 
strongly inhibitory (Table 4). In separate experi- 
ments, it was shown that radioactively labeled 
dCDP-DG was itself hydrolyzed by the enzyme at 
20% the rate observed with CDP-DG. In contrast, 
CDP-choline, CDP-glycerol, and sodium pyrophos- 
phate were not inhibitory. In view of the inhibition 
of the enzyme by AMP in the present experiments 
as we11 as of the bacterial enzyme (Raetz et al., 
1976) structural analogs of this nucleotide were in- 
vestigated. Both 5'-AMP and 5'-dAMP produced 
strong inhibition (over 90%), while a mixture of 2'- 
and 3'-AMP was less inhibitory. Substitution of the 


































Compounds Producing < 10% inhibition 
CDP-choline h a - A  
CDP-glycero I Ribose-5'-phosphate 
Sodium pyrophosphate CMP, IMP 
5'-Adenosine monosulfate Cyclic 3'5'-AMP 
cY,P-Methylene ATP Myo-inositol* 
Purified PM-10 retentate enzyme (approximately 7 p,g protein) 
was incubated for 30 or 60 min in the presence of inhibitors, 
as indicated. The concentration of CDP-dipalmitin was 0.23 mM 
and that of the inhibitors was 2.3 mM. 
a Equimolar concentrations of  inhibitor and substrate still 
produced 90% inhibition. 
Also tested at 1.0 mM. In addition, enzyme and substrate 
were incubated with inositol and Mg2+ at pH 8.3. N o  CDP-DG: 
inositol transferase activity was detected. 
5'-phosphate by sulfate destroyed the inhibitory 
effect. While ATP produced some inhibition, the 
a,p-methylene derivative was not inhibitory, a re- 
sult suggesting that some degradation of ATP to 
AMP may account for the observed inhibition. The 
p,y-methylene derivative of ATP, which is easily 
hydrolyzed to AMP, was inhibitory. Ara-C, a po- 
tential chemotherapeutic agent (Raetz et al., 1977) 
was inhibitory, as were both ara-CMP and ara- 
AMP. Ara-A was without effect. Adenosine 5'-0- 
thiomonophosphate was as effective an inhibitor as 
AMP. 
Tissue Distribution of CDP-DG Hydrolase 
CDP-DG hydrolase activities were detected in 
dialyzed homogenates of all organs tested. Spleen 
and brain extracts had comparable specific ac- 
tivities, while lung, kidney, heart, and liver were 
only slightly less active. 
DISCUSSION 
The data presented are consistent with the pres- 
ence in eukaryotic tissues of CDP-DG hydrolase 
activity. The brain enzyme appears to be lysosomal 
as judged from its distribution in subcellular frac- 
tions, its release upon freeze-thaw treatment, and 
its acidic pH optimum. It is unlikely that the ob- 
served activity could be accounted for by the action 
of other enzymes of CDP-DG metabolism. 
CTP:PhA cytidyl transferase purified from yeast 
(Belendiuk et al., 1978) or E. coli (Langley and 
Kennedy, 1978) has no CDP-DG hydrolase activity. 
In addition, the brain CDP-DG hydrolase prepara- 
tion is not affected by the addition of inorganic 
pyrophosphate and has no divalent cation require- 
ment. The lack of a metal requirement, the distribu- 
tion of the hydrolase in brain subcellular fractions, 
and the observed pH optimum also rule out a role 
for CDP-DG:inositol transferase in the observed 
hydrolytic activity. Furthermore, the addition of 1 
mM-inositol did not stimulate release of water- 
soluble radioactivity. The observed lysosomal dis- 
tribution also speaks against the possibility that the 
observed activity can be attributed to a nonspecific 
nucleotide pyrophosphatase, since this class of en- 
zymes is characterized by a somewhat alkaline pH 
optimum, a localization in microsomal and plasma 
membrane fractions and frequently, but not in- 
variantly, a divalent cation requirement (Schlisel- 
feld et al., 1965; Bischoff et al., 1975). The brain 
CDP-DG hydrolase was also unaffected by the 
presence of a 10-fold excess of CDP-choline. 
The conversion of CDP-DG to phosphatidylino- 
sitol (PhI) catalyzed by CDP-DG:inositol transfer- 
ase has been demonstrated to be reversible (Petzold 
and Agranoff, 1965; 1967). The reverse reaction, 
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coupled with CDP-DG hydrolase, yields a phos- 
pholipase D-like conversion of PhI to PhA and 
myo-inositol: 
PhI + CMP % CDP-DG + myo-inositol 
CDP-DG + HZO + CMP + PhA 
Net PhI + H,O + PhA + myo-inositol 
A phospholipase D action in the pancreas has 
been invoked to explain a “phospholipid labeling 
effect,” i.e., increased labeling of PhI and PhA from 
32Pi (Hokin-Neaverson et al., 1978). In pancreas, 
unlike brain, a net decrease in the amount of PhI 
and commensurate increase in PhA is seen follow- 
ing addition of cholecystokinin (pancreazymin) or 
acetylcholine. Different intracellular localizations 
and pH optima for the hydrolase and transferase, 
however, render this hypothesis less attractive. 
The brain enzyme differs from bacterial CDP-DG 
hydrolase in a number of ways. The bacterial en- 
zyme is not reported to have an acidic pH optimum, 
is inactive against dCDP-DG, and is not inhibited by 
the deoxy-liponucleotide (Raetz, 1972). In contrast, 
the present studies indicate that the brain enzyme 
cleaves dCDP-DG, and CDP-DG hydrolysis is 
blocked by the presence of dCDP-DG. 
dCDP-DG is found in bacteria in equimolar 
amounts with CDP-DG (Raetz et al., 1976). The 
CTP:PhA cytidyl transferase of bacteria accepts 
dCTP and CTP equally well, and both nucleotides 
can be utilized to form bacterial lipids. Since there 
is much more CTP available in bacteria than dCTP, 
it has been suggested that the differential action of 
the hydrolase may be responsible for the unexpect- 
edly high levels of dCDP-DG found in bacteria. 
The significance of the two precursors, seemingly 
equally suitable, is unknown. In yeast, the 
CTP:PhA cytidyl transferase accepts only CTP as a 
substrate and hence dCDP-DG is not found. In liver 
and brain, both triphosphates are accepted, but only 
CDP-DG has so far been isolated from tissue. The 
absence of dCDP-DG in animals can be accounted 
for by the relatively low amount of dCTP available 
for dCDP-DG synthesis, since the hydrolase in 
brain (unlike bacteria) can utilize both CDP-DG and 
dCDP-DG as substrates. 
Of the various enzymes of liponucleotide 
metabolism, those of synthesis appear rate-limiting, 
a concept supported by the low steady state levels 
of liponucleotides in sources, so far examined. Hy- 
drolase rates are generally of the order of, or 
greater than, lipid biosynthetic reactions (Carter 
and Kennedy, 1966; Petzold and Agranoff, 1967). 
The highly specific inhibition by AMP in both bac- 
terial and mammalian enzymes is unexplained, 
but may be related to a regulatory mechanism. 
The presence of CDP-DG hydrolase in brain was 
postulated previously by Eliasson et al. (1972), who 
found that brain from rabbits with a hereditary atax- 
ia was inefficient in producing PhI from added 
CDP-DG precursor. It is possible that the patho- 
logical changes in the animals led to increased 
lysosomal content secondary to degenerative 
changes and, hence, to increased CDP-DG hydro- 
lase activity. 
Liponucleotides have been proposed as conve- 
nient forms for the introduction of chemotherapeu- 
tic agents. For example, ara-C has been introduced 
into experimental animals in the form of ara- 
CDP-DG liposomes (Raetz et al., 1977). It is pro- 
posed that the micelles are readily picked up by 
cells and then cleaved by CDP-DG:inositol trans- 
ferase to form ara-CMP and phosphatidylinositol, 
thus additionally bypassing the nucleoside kinase 
step, thought to be rate-limiting. From the present 
experiments, it appears more likely that the ara- 
CDP-DG is cleaved by CDP-DG hydrolase. If the 
micelles are picked up by endocytosis, they are 
likely to come in contact with lysosomal enzymes 
immediately upon entry into the cell. Although the 
activity of mammalian CDP-DG hydrolase against 
ara-CDP-DG is as yet unknown, this possibility 
should be given consideration in view of the low 
specificity of the mammalian enzyme. 
Note added in proof: In subsequent experiments, 
the apparent KM toward CDP-dipalmitin has varied 
from 64 to 127 PM, possibly reflecting the lipid 
content in a given preparation of partially purified 
enzyme. 
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